Camila T da Silva

Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors.

F. Costa, I. Cavalli, R. Lima, 2016, Revista da Associacao Medica Brasileira.